FDA Approved Many New Drugs in 2022 That Will Improve the Lives of Patients and Consumers FDA FDA Grants Accelerated Approval to Ponatinib Plus Chemotherapy in First Line Ph+ ALL AJMC The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Analysis: The peptide problem: Hype is outrunning the evidence McMaster News New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,